Suven Life Sciences Share Price
286.10+0.00 (+1.18%)
+36.62% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SUVENNSE
Suven Life Sciences Share Price
286.10+0.00 (+1.18%)
+36.62% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| -35% | -12% | -19% | 7% |
| - | - | - | -72% |
| 4% | 22% | 59% | 37% |
| -51% | -83% | -73% | -102% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
LAURUSLABS
CIPLA
DRREDDY
MANKIND
AUROPHARMA
LUPIN
SUVEN
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,760 | ₹421539 Cr | 34.85 | 12.07 | 62.82 | ₹11479 Cr |
| 9,426 | ₹247576 Cr | 84.64 | 34.04 | 128.41 | ₹2568 Cr |
| 4,682 | ₹177251 Cr | 81.27 | 16.72 | 97.06 | ₹2163 Cr |
| 1,134.4 | ₹111232 Cr | 24.65 | 9.42 | 62.53 | ₹5040 Cr |
| 2,069.2 | ₹109797 Cr | 100.42 | 6.8 | 29.25 | ₹889 Cr |
| 1,311.3 | ₹105290 Cr | 31.24 | 9.77 | 57.87 | ₹3879 Cr |
| 1,229.4 | ₹99753 Cr | 30.96 | 5.32 | 63.99 | ₹4196 Cr |
| 2,400 | ₹97850 Cr | 47.9 | 13.75 | 71.08 | ₹1913 Cr |
| 1,706.9 | ₹97015 Cr | 26.13 | 17.95 | 96.84 | ₹3505 Cr |
| 1,935 | ₹89629 Cr | 16.21 | 30.95 | 154.35 | ₹5333 Cr |
| 286.1 | ₹7989 Cr | — | -4.83 | -12.25 | -₹276 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹92 L | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹9 Cr | ₹1 Cr | ₹9 Cr | ₹3 Cr | ₹274 Cr | ₹199 Cr | ₹253 Cr | ₹2 Cr | ₹90 Cr | ₹192 Cr |
| ₹8 Cr | ₹7 Cr | ₹3 Cr | ₹4 Cr | ₹60 L | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹2 Cr | ₹21 L | ₹44 L | ₹12 L | ₹14 L | ₹50 L | ₹84 L | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹6 Cr | ₹6 Cr | ₹3 Cr | ₹4 Cr | ₹7 Cr | ₹7 Cr | ₹8 Cr |
| ₹11 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹7 Cr | ₹5 Cr | ₹7 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹8 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹11 Cr | ₹4 Cr | ₹12 Cr | ₹9 Cr | ₹280 Cr | ₹202 Cr | ₹257 Cr | ₹9 Cr | ₹96 Cr | ₹200 Cr |
| ₹138 Cr | ₹54 Cr | ₹108 Cr | ₹82 Cr | ₹54 Cr | ₹47 Cr | ₹42 Cr | ₹56 Cr | ₹33 Cr | ₹34 Cr | ₹50 Cr | ₹28 Cr | ₹33 Cr | ₹36 Cr | ₹56 Cr | ₹28 Cr | ₹26 Cr | ₹25 Cr | ₹38 Cr | ₹30 Cr | ₹46 Cr | ₹24 Cr | ₹29 Cr | ₹28 Cr | ₹17 Cr | ₹35 Cr | ₹31 Cr | ₹178 Cr | ₹145 Cr | ₹184 Cr | ₹23 Cr | ₹85 Cr | ₹152 Cr |
| -₹125 Cr | -₹44 Cr | -₹101 Cr | -₹76 Cr | -₹50 Cr | -₹43 Cr | -₹38 Cr | -₹48 Cr | -₹27 Cr | -₹26 Cr | -₹40 Cr | -₹18 Cr | -₹22 Cr | -₹26 Cr | -₹49 Cr | -₹21 Cr | -₹21 Cr | -₹20 Cr | -₹32 Cr | -₹27 Cr | -₹42 Cr | -₹20 Cr | -₹25 Cr | -₹15 Cr | -₹12 Cr | -₹22 Cr | -₹22 Cr | ₹108 Cr | ₹62 Cr | ₹79 Cr | -₹13 Cr | ₹17 Cr | ₹54 Cr |
| ₹48 L | ₹16 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹80,000 | ₹2 L | ₹2 L | ₹3 L | ₹4 L | ₹4 L | ₹5 L | ₹5 L | ₹6 L | ₹7 L | ₹10 L | ₹10 L | ₹13 L | ₹15 L | ₹15 L | ₹24 L | ₹18 L | ₹26 L | ₹22 L | ₹23 L | ₹10 L | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹0 | ₹59 L | ₹1 Cr |
| -₹128 Cr | -₹46 Cr | -₹102 Cr | -₹77 Cr | -₹52 Cr | -₹44 Cr | -₹39 Cr | -₹50 Cr | -₹28 Cr | -₹28 Cr | -₹42 Cr | -₹13 Cr | -₹24 Cr | -₹28 Cr | -₹51 Cr | -₹23 Cr | -₹16 Cr | -₹21 Cr | -₹34 Cr | -₹28 Cr | -₹39 Cr | -₹22 Cr | -₹26 Cr | -₹17 Cr | -₹13 Cr | -₹23 Cr | -₹23 Cr | ₹100 Cr | ₹55 Cr | ₹72 Cr | -₹14 Cr | ₹11 Cr | ₹47 Cr |
| -₹128 Cr | -₹46 Cr | -₹102 Cr | -₹77 Cr | -₹52 Cr | -₹44 Cr | -₹39 Cr | -₹50 Cr | -₹28 Cr | -₹27 Cr | -₹42 Cr | -₹13 Cr | -₹24 Cr | -₹28 Cr | -₹51 Cr | -₹23 Cr | -₹16 Cr | -₹21 Cr | -₹34 Cr | -₹28 Cr | -₹39 Cr | -₹22 Cr | -₹24 Cr | -₹16 Cr | -₹10 Cr | -₹26 Cr | -₹23 Cr | ₹63 Cr | ₹26 Cr | ₹38 Cr | -₹14 Cr | ₹4 Cr | ₹26 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2008 | Mar 2007 | Mar 2006 | Mar 2005 | Mar 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹26 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹15 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| ₹157 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹37 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹408 Cr | ₹87 Cr | ₹248 Cr | ₹354 Cr | ₹82 Cr | ₹58 Cr | ₹131 Cr | ₹226 Cr | ₹755 Cr | ₹654 Cr | ₹583 Cr | ₹547 Cr | ₹95 Cr | ₹96 Cr | ₹85 Cr | ₹76 Cr | ₹77 Cr |
| ₹408 Cr | ₹87 Cr | ₹248 Cr | ₹354 Cr | ₹82 Cr | ₹58 Cr | ₹131 Cr | ₹226 Cr | ₹755 Cr | ₹654 Cr | ₹583 Cr | ₹547 Cr | ₹95 Cr | ₹96 Cr | ₹85 Cr | ₹76 Cr | ₹77 Cr |
| ₹591 Cr | ₹110 Cr | ₹270 Cr | ₹375 Cr | ₹96 Cr | ₹108 Cr | ₹143 Cr | ₹239 Cr | ₹767 Cr | ₹667 Cr | ₹595 Cr | ₹559 Cr | ₹106 Cr | ₹102 Cr | ₹90 Cr | ₹81 Cr | ₹82 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹25 L | ₹23 Cr | ₹38 Cr | ₹55 Cr | ₹55 Cr | ₹41 Cr | ₹24 Cr | ₹20 Cr | ₹21 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹39 L | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹6 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹6 Cr | ₹20 Cr | ₹23 Cr | -₹2 Cr | -₹5 Cr | ₹23 Cr | ₹2 Cr | ₹5 Cr | ₹7 Cr | ₹13 Cr | ₹10 Cr |
| ₹12 Cr | ₹0 | ₹0 | ₹58 L | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹76 L | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹14 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹5 Cr | ₹12 Cr | ₹25 Cr | ₹30 Cr | ₹28 Cr | ₹41 Cr | ₹86 Cr | ₹57 Cr | ₹47 Cr | ₹31 Cr | ₹33 Cr | ₹31 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹5 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹6 Cr | ₹7 Cr | ₹57 Cr | ₹38 Cr | ₹36 Cr | ₹44 Cr | ₹20 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹7 Cr |
| ₹12 Cr | ₹17 Cr | ₹10 Cr | ₹8 Cr | ₹5 Cr | ₹12 Cr | ₹20 Cr | ₹32 Cr | ₹29 Cr | ₹46 Cr | ₹48 Cr | ₹42 Cr | ₹63 L | ₹1 Cr | ₹29 L | ₹27 L | ₹21 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹31 Cr | ₹30 Cr | ₹24 Cr | ₹28 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹95 Cr | ₹95 Cr | ₹95 Cr | ₹94 Cr | ₹118 Cr | ₹109 Cr | ₹93 Cr | ₹103 Cr | ₹13 Cr | ₹14 Cr | ₹12 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr |
| ₹19 Cr | ₹23 Cr | ₹14 Cr | ₹105 Cr | ₹102 Cr | ₹110 Cr | ₹120 Cr | ₹157 Cr | ₹226 Cr | ₹208 Cr | ₹211 Cr | ₹127 Cr | ₹35 Cr | ₹25 Cr | ₹22 Cr | ₹22 Cr | ₹16 Cr |
| ₹624 Cr | ₹135 Cr | ₹285 Cr | ₹483 Cr | ₹202 Cr | ₹222 Cr | ₹275 Cr | ₹421 Cr | ₹1023 Cr | ₹903 Cr | ₹846 Cr | ₹773 Cr | ₹199 Cr | ₹173 Cr | ₹143 Cr | ₹136 Cr | ₹129 Cr |
| ₹6 Cr | ₹6 Cr | ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹8 L | ₹10 Cr | ₹9 Cr | ₹7 Cr | ₹12 Cr | ₹7 Cr | ₹4 Cr | ₹3 Cr | ₹6 Cr | ₹3 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹48 L | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹34 Cr | ₹71 Cr | ₹83 Cr | ₹109 Cr | ₹55 Cr | ₹41 Cr | ₹24 Cr | ₹20 Cr | ₹21 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹130 Cr | ₹113 Cr | ₹78 Cr | ₹88 Cr | ₹83 Cr | ₹67 Cr | ₹77 Cr | ₹39 Cr | ₹376 Cr | ₹349 Cr | ₹325 Cr | ₹291 Cr | ₹141 Cr | ₹120 Cr | ₹102 Cr | ₹89 Cr | ₹78 Cr |
| ₹57 Cr | ₹53 Cr | ₹50 Cr | ₹51 Cr | ₹46 Cr | ₹46 Cr | ₹52 Cr | ₹17 Cr | ₹68 Cr | ₹43 Cr | ₹20 Cr | ₹119 Cr | ₹31 Cr | ₹25 Cr | ₹19 Cr | ₹14 Cr | ₹10 Cr |
| ₹73 Cr | ₹60 Cr | ₹28 Cr | ₹37 Cr | ₹38 Cr | ₹21 Cr | ₹25 Cr | ₹22 Cr | ₹308 Cr | ₹306 Cr | ₹305 Cr | ₹172 Cr | ₹110 Cr | ₹96 Cr | ₹83 Cr | ₹74 Cr | ₹67 Cr |
| ₹4 Cr | ₹97,000 | ₹0 | ₹0 | ₹4 Cr | ₹5 Cr | ₹0 | ₹2 L | ₹25 Cr | ₹10 Cr | ₹7 Cr | ₹107 Cr | ₹4 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹7 L | ₹7 L | ₹7 L | ₹0 | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹7 Cr | ₹15 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹7 L | ₹7 L | ₹7 L | ₹0 | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹7 Cr | ₹15 Cr |
| ₹91 L | ₹5 L | ₹2 L | ₹11 L | ₹33 L | ₹0 | ₹91 Cr | ₹0 | ₹17 Cr | ₹6 Cr | ₹6 Cr | ₹11 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹100 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹20 L | ₹20 L | ₹0 | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹78 Cr | ₹60 Cr | ₹28 Cr | ₹137 Cr | ₹41 Cr | ₹26 Cr | ₹116 Cr | ₹22 Cr | ₹350 Cr | ₹322 Cr | ₹319 Cr | ₹291 Cr | ₹116 Cr | ₹106 Cr | ₹90 Cr | ₹85 Cr | ₹84 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹181 Cr | ₹22 Cr | ₹76 Cr | ₹46 Cr | ₹45 Cr | ₹9 L | ₹5 L | ₹223 Cr | ₹279 Cr | ₹301 Cr | ₹5 L | ₹4 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹10 L | ₹24 L | ₹71 L | ₹0 | ₹2 L | ₹14 L | ₹0 | ₹0 | ₹139 Cr | ₹93 Cr | ₹83 Cr | ₹82 Cr | ₹24 Cr | ₹23 Cr | ₹23 Cr | ₹19 Cr | ₹12 Cr |
| ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹81 L | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹62 Cr | ₹46 Cr | ₹54 Cr | ₹40 Cr | ₹36 Cr | ₹16 Cr | ₹15 Cr | ₹19 Cr | ₹11 Cr |
| ₹337 Cr | ₹38 Cr | ₹164 Cr | ₹184 Cr | ₹6 Cr | ₹47 Cr | ₹15 Cr | ₹69 L | ₹28 Cr | ₹9 Cr | ₹241 Cr | ₹280 Cr | ₹3 Cr | ₹10 Cr | ₹1 Cr | ₹3 Cr | ₹12 Cr |
| ₹5 Cr | ₹1 Cr | ₹3 Cr | ₹5 Cr | ₹1 Cr | ₹3 Cr | ₹35 L | ₹20 L | ₹14 Cr | ₹8 Cr | ₹3 Cr | ₹41 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr |
| ₹22 Cr | ₹13 Cr | ₹12 Cr | ₹109 Cr | ₹107 Cr | ₹145 Cr | ₹142 Cr | ₹172 Cr | ₹151 Cr | ₹125 Cr | ₹146 Cr | ₹34 Cr | ₹15 Cr | ₹14 Cr | ₹10 Cr | ₹9 Cr | ₹8 Cr |
| ₹547 Cr | ₹75 Cr | ₹257 Cr | ₹345 Cr | ₹160 Cr | ₹197 Cr | ₹160 Cr | ₹398 Cr | ₹674 Cr | ₹581 Cr | ₹528 Cr | ₹477 Cr | ₹83 Cr | ₹68 Cr | ₹53 Cr | ₹51 Cr | ₹45 Cr |
| ₹528 Cr | ₹52 Cr | ₹243 Cr | ₹240 Cr | ₹58 Cr | ₹87 Cr | ₹39 Cr | ₹241 Cr | ₹448 Cr | ₹373 Cr | ₹317 Cr | ₹350 Cr | ₹48 Cr | ₹43 Cr | ₹31 Cr | ₹30 Cr | ₹29 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹5 Cr | ₹2 L | ₹4 L | ₹6 L | ₹9 L | ₹11 L |
| ₹624 Cr | ₹135 Cr | ₹285 Cr | ₹483 Cr | ₹202 Cr | ₹222 Cr | ₹275 Cr | ₹421 Cr | ₹1023 Cr | ₹903 Cr | ₹846 Cr | ₹773 Cr | ₹199 Cr | ₹173 Cr | ₹143 Cr | ₹136 Cr | ₹129 Cr |
| ₹16 | ₹5 | ₹12 | ₹17 | ₹7 | ₹6 | ₹11 | ₹19 | ₹60 | ₹52 | ₹47 | ₹44 | ₹9 | ₹35 | ₹36 | ₹32 | ₹33 |
| ₹16 | ₹5 | ₹12 | ₹17 | ₹6 | ₹5 | ₹10 | ₹17 | ₹56 | ₹48 | ₹43 | ₹40 | ₹8 | ₹32 | ₹9 | ₹8 | ₹8 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2008 | Mar 2007 | Mar 2006 | Mar 2005 | Mar 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -₹276 Cr | -₹161 Cr | -₹106 Cr | -₹118 Cr | -₹122 Cr | -₹77 Cr | -₹106 Cr | ₹16 L | ₹196 Cr | ₹123 Cr | ₹98 Cr | ₹152 Cr | ₹6 Cr | ₹11 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr |
| -₹6 Cr | -₹4 Cr | -₹22 Cr | -₹8 Cr | -₹1 Cr | -₹3 Cr | -₹8 Cr | -₹5 Cr | ₹10 Cr | ₹13 Cr | ₹11 Cr | ₹21 Cr | ₹11 Cr | ₹7 Cr | ₹7 Cr | ₹4 Cr | ₹3 Cr |
| -₹18 Cr | ₹10 Cr | ₹7 Cr | ₹11 Cr | -₹4 Cr | -₹15 Cr | -₹17 Cr | -₹33 Cr | -₹92 Cr | ₹8 Cr | -₹14 Cr | ₹8 Cr | -₹13 Cr | ₹46 L | -₹7 Cr | -₹7 Cr | -₹6 Cr |
| -₹301 Cr | -₹155 Cr | -₹122 Cr | -₹115 Cr | -₹127 Cr | -₹95 Cr | -₹132 Cr | -₹38 Cr | ₹113 Cr | ₹144 Cr | ₹94 Cr | ₹181 Cr | ₹5 Cr | ₹18 Cr | ₹7 Cr | ₹3 Cr | ₹5 Cr |
| -₹301 Cr | -₹154 Cr | -₹115 Cr | -₹116 Cr | -₹128 Cr | -₹96 Cr | -₹135 Cr | -₹53 Cr | ₹70 Cr | ₹109 Cr | ₹67 Cr | ₹143 Cr | ₹4 Cr | ₹16 Cr | ₹6 Cr | ₹2 Cr | ₹4 Cr |
| -₹462 Cr | ₹155 Cr | ₹94 Cr | -₹248 Cr | -₹22 Cr | ₹56 Cr | ₹146 Cr | ₹37 Cr | -₹61 L | -₹311 Cr | -₹39 Cr | -₹110 Cr | -₹16 Cr | -₹20 Cr | -₹9 Cr | -₹4 Cr | -₹31 Cr |
| ₹757 Cr | -₹76 L | -₹1 Cr | ₹396 Cr | ₹146 Cr | ₹35 Cr | ₹3 Cr | ₹5 Cr | -₹52 Cr | -₹30 Cr | -₹68 Cr | ₹179 Cr | ₹6 Cr | ₹13 Cr | ₹3 Cr | -₹8 Cr | ₹38 Cr |
| -₹7 Cr | ₹9 L | -₹22 Cr | ₹32 Cr | -₹4 Cr | -₹5 Cr | ₹14 Cr | -₹11 Cr | ₹17 Cr | -₹232 Cr | -₹39 Cr | ₹212 Cr | -₹7 Cr | ₹8 Cr | -₹1 Cr | -₹10 Cr | ₹11 Cr |
| ₹15 Cr | ₹15 Cr | ₹37 Cr | ₹5 Cr | ₹9 Cr | ₹15 Cr | ₹23 L | ₹18 Cr | ₹9 Cr | ₹241 Cr | ₹280 Cr | ₹68 Cr | ₹10 Cr | ₹1 Cr | ₹3 Cr | ₹12 Cr | ₹71 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹7 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹10 L |
| ₹8 Cr | ₹15 Cr | ₹15 Cr | ₹37 Cr | ₹5 Cr | ₹9 Cr | ₹15 Cr | ₹23 L | ₹26 Cr | ₹9 Cr | ₹241 Cr | ₹279 Cr | ₹3 Cr | ₹10 Cr | ₹1 Cr | ₹3 Cr | ₹12 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Suven Life Sciences Share Price
286.10+0.00 (+1.18%)
+36.62% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 oscillators
RSI
29.32Sell
STOCH %K
8.37Buy
MACD Level(12,26)
-15.82Sell
Ultimate Oscillator
24.69Sell
Aroon Oscillator
-52.00Sell
BOP
0.12Buy
CCI
-134.17Buy
Williams %R
-91.63Buy
Momentum
-51.80Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
301.92Sell
SMA 9
303.56Sell
EMA 21
319.44Sell
SMA 21
324.59Sell
EMA 50
326.69Sell
SMA 50
339.41Sell
EMA 200
270.39Buy
SMA 200
241.00Buy
WMA 20
312.18Sell
Pivot
Pivot
Classic
Resistance 5
324.50
Resistance 4
314.55
Resistance 3
304.60
Resistance 2
294.65
Resistance 1
288.70
Pivot
284.70
Support 1
278.75
Support 2
274.75
Support 3
264.80
Support 4
254.85
Support 5
244.90
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Suven Life Sciences Share Price
286.10+0.00 (+1.18%)
+36.62% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 70.08% | 70.15% | 67.36% | 67.36% | 70.27% | 70.27% |
| 0.56% | 0.91% | 1.07% | 1.17% | 0.58% | 0.25% |
| 2.92% | 2.83% | 1.31% | 1.31% | 0.01% | 0.00% |
| 0.01% | 1.79% | 2.08% | 2.08% | 0.01% | 0.01% |
| 26.43% | 24.32% | 28.18% | 28.08% | 29.13% | 29.47% |
Bulk & block deals
Name
Graviton Research Capital Llp
Graviton Research Capital Llp
Graviton Research Capital Llp
Graviton Research Capital Llp
Graviton Research Capital Llp
Graviton Research Capital Llp
Alpha Leon Enterprises Llp
Alpha Leon Enterprises Llp
Katkar Sanjay
Alpha Leon Enterprises Llp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 11 Jan 2024 | Purchase | 17.40 Cr | ₹121.82 | 14.29 L | Bulk | 0.505567 | NSE |
| 11 Jan 2024 | Sell | 17.39 Cr | ₹121.70 | 14.29 L | Bulk | 0.505567 | NSE |
| 13 Sep 2023 | Purchase | 11.99 Cr | ₹78.12 | 15.35 L | Bulk | 0.543222 | NSE |
| 13 Sep 2023 | Sell | 12 Cr | ₹78.20 | 15.35 L | Bulk | 0.543222 | NSE |
| 23 Apr 2021 | Purchase | 7.03 Cr | ₹109.64 | 6.41 L | Bulk | 0.226838 | NSE |
| 23 Apr 2021 | Sell | 7.05 Cr | ₹109.97 | 6.41 L | Bulk | 0.226838 | NSE |
| 17 Dec 2020 | Purchase | 6.89 Cr | ₹104.94 | 6.56 L | Bulk | 0.232329 | NSE |
| 17 Dec 2020 | Sell | 6.59 Cr | ₹105.08 | 6.27 L | Bulk | 0.222061 | NSE |
| 18 Sep 2020 | Purchase | 3.88 Cr | ₹56.27 | 6.89 L | Bulk | 0.243802 | NSE |
| 21 Apr 2020 | Purchase | 2.23 Cr | ₹29.75 | 7.50 L | Bulk | 0.265433 | NSE |
Insider trading & SAST
Client name
Jasti Property & Equity Holdings Pvt Ltd & Pacs
Jasti Property And Equity Holdings Private Limited (In Its Capacity As Sole Trustee Of Jasti Family Trust)
Jasti Property And Equity Holdings Private Limited (In Its Capacity As Sole Trustee Of The Jasti Family Trust)
Sudharani Jasti
Sudharani Jasti
Jasti Property & Equity Holdings Pvt Ltd & Pacs
Jasti Property & Equity Holdings Pvt Ltd & Pacs
Jasti Property And Equity Holdings Private Limited (In Its Capacity As Sole Trustee Of The Jasti Family Trust)
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08 May 2026 | Promoter | Acquisition | 4.17 | 70.15 | 0 | — | 3.18 Cr | 06 Mar 2026 | Pref. Allotment | 18,50,00,000 | SAST | 29(2) | — |
| 10 Mar 2026 | Promoter Group | Acquisition | 12.046372 | 69.57 | 425.70 Cr | ₹134 | 3.18 Cr | 06 Mar 2026 | Conversion of security | 18,34,66,264 | Insider Trading | — | Equity Shares |
| 07 Jul 2025 | Promoter Group | Acquisition | 14.567903 | 0 | 425.70 Cr | ₹134 | 3.18 Cr | 03 Jul 2025 | Allotment | 3,17,68,764 | Insider Trading | — | Warrants |
| 29 May 2024 | Promoter | Acquisition | 0.7 | 0.7 | 0 | — | 15.26 L | 28 May 2024 | Transmission | 15,28,535 | SAST | 29(2) | — |
| 29 May 2024 | Promoter & Director | Acquisition | 0.69955 | 0.7 | 0 | — | 15.26 L | 28 May 2024 | Others | 15,28,535 | Insider Trading | — | Equity Shares |
| 22 Nov 2022 | Promoter | Acquisition | 4.59 | 69.57 | 0 | — | 5.72 Cr | 16 Nov 2022 | Rights Issue | 15,17,05,701 | SAST | 29(2) | — |
| 30 Mar 2022 | Promoter | Acquisition | 4.98 | 64.98 | 0 | — | 1.81 Cr | 28 Mar 2022 | Pref. Allotment | 9,44,70,000 | SAST | 29(2) | — |
| 29 Mar 2022 | Promoter Group | Acquisition | 14.220393 | 64.98 | 147.64 Cr | ₹81.57 | 1.81 Cr | 28 Mar 2022 | Conversion of security | 9,44,65,000 | Insider Trading | — | Equity Shares |
Suven Life Sciences Share Price
286.10+0.00 (+1.18%)
+36.62% past 1 Year
Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team
Corporate Actions
Date
Type
Details
Company details
Suven Life Sciences Share Price
286.10+0.00 (+1.18%)
+36.62% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Suven Life Sciences Share Price
286.10+0.00 (+1.18%)
+36.62% past 1 Year
News
Suven Life Sciences completes enrolment in global phase-3 Alzheimer’s trial
Equity
SUVEN
Suven Life Sciences Q1 FY27 loss widens despite modest revenue growth
Equity
SUVEN
Suven Life plans major neuroscience push and Singapore expansion by FY27
Equity
SUVEN
Suven Life Sciences to showcase Alzheimer’s pipeline data at AAIC 2026
Equity
SUVEN
Suven Life Sciences raises Rs 248.84 crores via warrant conversion, adds Singapore unit
Equity
SUVEN
Suven Life Sciences to present CNS pipeline, seek partnerships at BIO 2026
Equity
SUVEN
Suven Life Sciences reports positive topline data for key depression drug trial
Equity
SUVEN
Suven Life Sciences advances key CNS asset after positive Phase-1 data
Equity
SUVEN
Suven Life Sciences presents Samelisant clinical data at SLEEP-2026 meet
Equity
SUVEN
Suven Life Sciences advances global Phase 3 Alzheimer’s agitation trial successfully
Equity
SUVEN
Suven Life Sciences Achieves 76% Enrollment in Phase 3 Trial for Masupirdine in Alzheimer’s Agitation
Equity
SUVEN
Suven Life Sciences Issues 3.17 Cr Equity Shares on Warrant Conversion Raising Rs 425.70 Cr.
Equity
SUVEN
Suven Life Sciences Ltd Reports Q3 Consolidated Net Loss of Rs 102 Crores vs Rs 39.12 Crores YoY.
Equity
SUVEN
Suven Life Sciences hits full enrollment early in key Ropanicant Phase-2b trial
Equity
SUVEN
Suven Life Sciences reports higher Q2 consolidated net loss year-on-year for FY2025-26.
Equity
SUVEN
Sunil Singhania Abakkus Diversified Alpha Fund Acquires 1.32 Percent Stake in Suven Life Sciences Q2
Equity
SUVEN
Suven Life Sciences: Q1 Sl Net Loss 14.80 Crores Rupees Vs Loss 7.70 Crores (Yoy) || Q1 Revenue 1.90 Crores Rupees Vs 1.00 Crores (Yoy)
Equity
SUVEN
Suven Life Sciences - Quaterly Results
Equity
SUVEN
Suven Life Sciences reports Profit after tax of Rs -14.78 Crores, in the June 2025 quarter
Equity
SUVEN
Suven Life Sciences - Quaterly Results
Equity
SUVEN